(Total Views: 394)
Posted On: 02/20/2021 1:45:23 PM
Post# of 145900
LLMab has superior half life, doesn't get broken down via liver / via cyp450 pathway (low toxicity risk), and binds to other of the CCR5 loops, not the active site.. it's a one-in-a-billion or trillion molecule. Cost will eventually come down but since a large part of that will go to scaling up production, it's well worth it.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)